107 related articles for article (PubMed ID: 8422244)
1. The disulfide bond arrangement of leukemia inhibitory factor: homology to oncostatin M and structural implications.
Nicola NA; Cross B; Simpson RJ
Biochem Biophys Res Commun; 1993 Jan; 190(1):20-6. PubMed ID: 8422244
[TBL] [Abstract][Full Text] [Related]
2. Homology model for oncostatin M based on NMR structural data.
Kitchen D; Hoffman RC; Moy FJ; Powers R
Biochemistry; 1998 Jul; 37(30):10581-8. PubMed ID: 9692947
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation pattern and disulfide assignments of recombinant human differentiation-stimulating factor.
Schmelzer CH; Harris RJ; Butler D; Yedinak CM; Wagner KL; Burton LE
Arch Biochem Biophys; 1993 May; 302(2):484-9. PubMed ID: 8489250
[TBL] [Abstract][Full Text] [Related]
4. Solution dynamics and secondary structure of murine leukemia inhibitory factor: a four-helix cytokine with a rigid CD loop.
Purvis DH; Mabbutt BC
Biochemistry; 1997 Aug; 36(33):10146-54. PubMed ID: 9254611
[TBL] [Abstract][Full Text] [Related]
5. Human recombinant CuZn-superoxide dismutase. Amino acid sequence and location of the disulfide bond.
Peretz M; Werber MU; Burstein Y
Int J Pept Protein Res; 1991 Feb; 37(2):122-7. PubMed ID: 2019474
[TBL] [Abstract][Full Text] [Related]
6. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
Keck RG; Berleau L; Harris R; Keyt BA
Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
[TBL] [Abstract][Full Text] [Related]
7. The role of disulfide bonds in the structure and function of murine epidermal growth factor (mEGF).
Alewood D; Nielsen K; Alewood PF; Craik DJ; Andrews P; Nerrie M; White S; Domagala T; Walker F; Rothacker J; Burgess AW; Nice EC
Growth Factors; 2005 Jun; 23(2):97-110. PubMed ID: 16019431
[TBL] [Abstract][Full Text] [Related]
8. Complex conserved organization of the mammalian leukemia inhibitory factor gene: regulated expression of intracellular and extracellular cytokines.
Haines BP; Voyle RB; Pelton TA; Forrest R; Rathjen PD
J Immunol; 1999 Apr; 162(8):4637-46. PubMed ID: 10202003
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric mapping of disulfide bonds in recombinant human interleukin-13.
Tsarbopoulos A; Varnerin J; Cannon-Carlson S; Wylie D; Pramanik B; Tang J; Nagabhushan TL
J Mass Spectrom; 2000 Mar; 35(3):446-53. PubMed ID: 10767776
[TBL] [Abstract][Full Text] [Related]
10. Cloning of leukemia inhibitory factor (LIF) and its expression in the uterus during embryonic diapause and implantation in the mink (Mustela vison).
Song JH; Houde A; Murphy BD
Mol Reprod Dev; 1998 Sep; 51(1):13-21. PubMed ID: 9712313
[TBL] [Abstract][Full Text] [Related]
11. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto.
Lohmeyer M; Harrison PM; Kannan S; DeSantis M; O'Reilly NJ; Sternberg MJ; Salomon DS; Gullick WJ
Biochemistry; 1997 Apr; 36(13):3837-45. PubMed ID: 9092813
[TBL] [Abstract][Full Text] [Related]
12. Folding and structural characterization of highly disulfide-bonded beetle antifreeze protein produced in bacteria.
Liou YC; Daley ME; Graham LA; Kay CM; Walker VK; Sykes BD; Davies PL
Protein Expr Purif; 2000 Jun; 19(1):148-57. PubMed ID: 10833402
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor influences the timing of programmed synapses withdrawal from neonatal muscles.
Kwon YW; Abbondanzo SJ; Stewart CL; Gurney ME
J Neurobiol; 1995 Sep; 28(1):35-50. PubMed ID: 8586964
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry.
Hoffman RC; Jennings LL; Tsigelny I; Comoletti D; Flynn RE; Sudhof TC; Taylor P
Biochemistry; 2004 Feb; 43(6):1496-506. PubMed ID: 14769026
[TBL] [Abstract][Full Text] [Related]
15. Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli.
Merewether LA; Le J; Jones MD; Lee R; Shimamoto G; Lu HS
Arch Biochem Biophys; 2000 Mar; 375(1):101-10. PubMed ID: 10683254
[TBL] [Abstract][Full Text] [Related]
16. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties.
Mizejewski GJ; Eisele L; Maccoll R
Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636
[TBL] [Abstract][Full Text] [Related]
17. The structure of the murine Fc receptor for IgG. Assignment of intrachain disulfide bonds, identification of N-linked glycosylation sites, and evidence for a fourth form of Fc receptor.
Hibbs ML; Classon BJ; Walker ID; McKenzie IF; Hogarth PM
J Immunol; 1988 Jan; 140(2):544-50. PubMed ID: 2961814
[TBL] [Abstract][Full Text] [Related]
18. Location of disulfide bonds in the Na+, K(+)-ATPase alpha subunit.
Gevondyan NM; Gevondyan VS; Modyanov NN
Biochem Mol Biol Int; 1993 Jun; 30(2):347-55. PubMed ID: 8395926
[TBL] [Abstract][Full Text] [Related]
19. Peptide mapping and disulfide bond analysis of myeloid progenitor inhibitory chemokine and keratinocyte growth factor by matrix-assisted laser desorption ionization mass spectrometry.
Navale V; Kaushal P; Hunt S; Burducea I; Gentz R; Khan F; Vertes A
Anal Biochem; 1999 Feb; 267(1):125-34. PubMed ID: 9918664
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of beta-ribbon structures in peptides using disulfide bonds.
Aberle AM; Reddy HK; Heeb NV; Nambiar KP
Biochem Biophys Res Commun; 1994 Apr; 200(1):102-7. PubMed ID: 8166677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
